US 8968736
Human antibodies to GFRα3 and methods of use thereof
granted A61KA61K2039/505A61K39/001103
Quick answer
US patent 8968736 (Human antibodies to GFRα3 and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61K39/001103, A61K39/39533, A61K39/39541